Published in World J Cardiol on August 26, 2012
Predictors of Prolonged Hospital Stay in Status Migrainosus. Neurohospitalist (2016) 0.80
The Edmonton Symptom Assessment System 25 Years Later: Past, Present and Future Developments. J Pain Symptom Manage (2016) 0.78
Health care professionals' attitudes regarding palliative care for patients with chronic heart failure: an interview study. BMC Palliat Care (2016) 0.75
Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail Rev (2017) 0.75
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care (1991) 7.28
Assessment of pain. Br J Anaesth (2008) 5.35
The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry (2000) 4.75
The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc (2003) 3.79
Validation of the Edmonton Symptom Assessment Scale. Cancer (2000) 3.56
Mechanisms and models in heart failure: A combinatorial approach. Circulation (1999) 2.60
The need of a taxonomy. Pain (1979) 1.84
Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs (2005) 1.77
Symptoms, depression, and quality of life in patients with heart failure. J Card Fail (2007) 1.77
Palliative care in congestive heart failure. J Am Coll Cardiol (2009) 1.76
Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation (2007) 1.72
Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med (2009) 1.62
Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer (2005) 1.43
What is this thing called pain? J Clin Invest (2010) 1.37
What should be the core outcomes in chronic pain clinical trials? Arthritis Res Ther (2004) 1.26
Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation (1995) 1.26
The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev (2002) 1.09
Psychological distress and pain significantly increase before death in metastatic breast cancer patients. Psychosom Med (2003) 1.08
Heart failure: the hidden problem of pain. J Pain Symptom Manage (2009) 1.00
Pain and quality of life in hospitalized patients with heart failure. J Pain Symptom Manage (2008) 0.98
Pain and heart failure: unrecognized and untreated. Eur J Cardiovasc Nurs (2009) 0.98
Outpatient palliative care for chronic heart failure: a case series. J Palliat Med (2011) 0.95
Psychosocial functioning and physical symptoms in heart failure patients: a within-individual approach. J Psychosom Res (2004) 0.94
Patient experiences of anxiety, depression and acute pain after surgery: a longitudinal perspective. Int J Nurs Stud (2004) 0.93
The Mini-Cog versus the Mini-Mental State Examination and the Clock Drawing Test in daily clinical practice: screening value in a German Memory Clinic. Int Psychogeriatr (2011) 0.88
Palliative care in heart failure: addressing the largest care gap. Curr Opin Cardiol (2011) 0.88
Mechanisms and management of neuropathic pain in cancer. J Support Oncol (2004) 0.87
Investigating pain in heart failure patients: rationale and design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) study. J Card Fail (2008) 0.87
Caring for special populations: total pain theory in advanced heart failure: applications to research and practice. Nurs Forum (2009) 0.83
Mini-Cog and Mini-Mental State Examination: agreement in a cross-sectional study with an elderly sample. Dement Geriatr Cogn Disord (2012) 0.82
Health-related quality of life of Japanese patients with chronic heart failure: assessment using the Medical Outcome Study Short Form 36. Circ J (2003) 0.79
Do patients with chronic heart failure have chest pain? Int J Cardiol (2012) 0.77
Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res (2005) 1.78
Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J (2004) 1.77
Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv (2008) 1.44
Persistent sexual dysfunction impairs quality of life after cardiac transplantation. J Sex Med (2010) 1.38
Pictorial essay: Ultrasonography in 'tennis leg'. Indian J Radiol Imaging (2010) 1.08
Pilot study of palliative care consultation in patients with advanced heart failure referred for cardiac transplantation. J Palliat Med (2012) 1.06
Left main coronary artery thrombus: a case series with different outcomes. J Thromb Thrombolysis (2005) 1.06
Impact of dietary patterns and interventions on cardiovascular health. Circulation (2006) 1.05
A novel minimal-invasive model of chronic myocardial infarction in swine. Coron Artery Dis (2004) 1.00
Coxibs and heart disease: what we have learned and what else we need to know. J Am Coll Cardiol (2006) 0.98
Left ventricular noncompaction cardiomyopathy: updated review. Ther Adv Cardiovasc Dis (2013) 0.98
Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarction. J Am Coll Cardiol (2002) 0.93
Intrinsic cardiac origin of human cardiosphere-derived cells. Eur Heart J (2011) 0.93
Administration of vascular endothelial growth factor adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovasc Pharmacol Ther (2005) 0.92
Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates. J Heart Lung Transplant (2008) 0.92
Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients. Int J Behav Med (2013) 0.89
"How do cardiomyocytes die?" apoptosis and autophagic cell death in cardiac myocytes. J Card Fail (2006) 0.89
The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev (2012) 0.89
Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol (2012) 0.88
Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction. Am J Cardiol (2009) 0.87
How does the heart (not) die? The role of autophagy in cardiomyocyte homeostasis and cell death. Heart Fail Rev (2010) 0.87
Depression and anxiety predict decline in physical health functioning in patients with heart failure. Ann Behav Med (2011) 0.87
Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Eng (2004) 0.84
The effects of spirituality and religion on outcomes in patients with chronic heart failure. J Relig Health (2012) 0.84
Statin therapy in patients with diastolic heart failure. Clin Cardiol (2010) 0.84
The potential effects of IGF-1 and GH on patients with chronic heart failure. J Cardiovasc Pharmacol Ther (2011) 0.84
Failing the failing heart: a review of palliative care in heart failure. Rev Cardiovasc Med (2013) 0.84
The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease. Rev Cardiovasc Med (2008) 0.83
Left ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure. Ann Transplant (2011) 0.83
Avoidant coping moderates the association between anxiety and patient-rated physical functioning in heart failure patients. J Behav Med (2011) 0.82
Heart transplantation using bivalirudin as anticoagulant. Interact Cardiovasc Thorac Surg (2009) 0.81
Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies. J Cardiovasc Pharmacol Ther (2009) 0.81
Phenazopyridine-induced sulfhemoglobinemia. Ann Pharmacother (2005) 0.81
Listeria meningitis associated with infliximab. Ann Pharmacother (2004) 0.81
Pregnancy-associated spontaneous coronary artery dissection. Am J Obstet Gynecol (2007) 0.80
Syncope in adults: systematic review and proposal of a diagnostic and therapeutic algorithm. Int J Cardiol (2011) 0.80
Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. Am J Cardiol (2005) 0.79
The first year post-heart transplantation: use of immunosuppressive drugs and early complications. J Cardiovasc Pharmacol Ther (2008) 0.79
Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension. Ther Adv Respir Dis (2012) 0.79
Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation. Int J Cardiol (2006) 0.79
H1N1 virus infection associated with acute myocardial infarction in a young patient without coronary artery disease--first reported case. Acta Cardiol (2011) 0.79
Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus. Interact Cardiovasc Thorac Surg (2009) 0.79
Myths and truths of growth hormone and testosterone therapy in heart failure. Expert Rev Cardiovasc Ther (2011) 0.78
The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms. Rev Cardiovasc Med (2007) 0.78
Vasopressin antagonism: a future treatment option in heart failure. Eur Heart J (2005) 0.78
Ultrafiltration for the management of acute decompensated heart failure. J Card Fail (2008) 0.78
Is vitamin D deficiency associated with heart failure? A review of current evidence. J Cardiovasc Pharmacol Ther (2011) 0.78
Testosterone therapy: treatment of metabolic disturbances in heart failure. J Cardiovasc Pharmacol Ther (2010) 0.77
Growth hormone and testosterone in heart failure therapy. Expert Opin Pharmacother (2010) 0.77
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension. Vasc Health Risk Manag (2010) 0.77
Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients--the IMPROVED multi-centre study. Eur Heart J (2004) 0.77
Update on the safety of testosterone therapy in cardiac disease. Expert Opin Drug Saf (2011) 0.77
The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation. J Cardiovasc Pharmacol Ther (2010) 0.77
Review article: the new concept of interventional heart failure therapy--part 1: electrical therapy, treatment of CAD, fluid removal, and ventricular support. J Cardiovasc Pharmacol Ther (2010) 0.77
Impact of obesity in patients with congestive heart failure. Rev Cardiovasc Med (2009) 0.76
An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med (2012) 0.76
Heart transplantation in the elderly: why cardiac transplantation does not need to be limited to younger patients but can be safely performed in patients above 65 years of age. Ann Transplant (2010) 0.76
Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review. Clin Res Cardiol (2012) 0.75
Is there really hope for the future? Geriatrics and palliative care. J Am Geriatr Soc (2006) 0.75
Vineberg procedure for inadvertent injury to anomalous left anterior descending artery during tetralogy of fallot repair: four decades later. Tex Heart Inst J (2006) 0.75
Sexual function in women with heart disease and coronary artery disease. Int J Impot Res (2007) 0.75
Sexual dysfunction in cardiac rehabilitation patients is much more than simply an epiphenomenon and needs more study. Rev Esp Cardiol (2008) 0.75
The prognostic value of anemia in patients with diastolic heart failure. Tex Heart Inst J (2009) 0.75
Improved erectile function after cardiac resynchronization therapy in a patient with heart failure-a case report. J Sex Med (2009) 0.75
Acute cellular transplant rejection following laparoscopic adjustable gastric banding in a morbidly obese patient post heart transplantation. J Cardiovasc Med (Hagerstown) (2010) 0.75
Live three-dimensional echocardiography in diagnosis of interventricular septal perforation by pacemaker lead. Echocardiography (2006) 0.75
Heart failure therapy: beyond the guidelines. J Cardiovasc Med (Hagerstown) (2010) 0.75
Case of fulminant giant-cell myocarditis associated with polymyositis, treated with a biventricular assist device and subsequent heart transplantation. Heart Lung (2011) 0.75
Central post-stroke syndrome treated with parenteral lidocaine. J Pain Symptom Manage (2006) 0.75
Sudden death prophylaxis in heart failure. Int J Cardiol (2007) 0.75
The beneficial role of spiritual counseling in heart failure patients. J Relig Health (2014) 0.75
Clinical applications of bivalirudin in the cardiac catheterization laboratory. J Cardiovasc Pharmacol Ther (2010) 0.75
Erectile dysfunction as a complication of heart failure. Curr Heart Fail Rep (2010) 0.75
Palliative care issues in heart transplant candidates. Curr Opin Support Palliat Care (2015) 0.75
Does the United States economy affect heart failure readmissions? A single metropolitan center analysis. Clin Cardiol (2012) 0.75
Palliative care: it is time to move toward a comfort and cure model. J Palliat Med (2011) 0.75
Philosophical implications of the systemic and patient-oriented management of chronic heart failure. J Relig Health (2011) 0.75
Conivaptan: a selective vasopressin antagonist. Drugs Today (Barc) (2006) 0.75
Heart allograft transplanted twice. Eur J Cardiothorac Surg (2008) 0.75
What's in a Name? J Palliat Med (2006) 0.75
An agonist of liver X receptor slows valvular disease in a hypercholesterolemia mouse model. J Heart Valve Dis (2010) 0.75